Menu
Home / Bioinformatics / Whole Exome Analysis

Whole Exome Analysis (WES)

Focusing on the 1-2% of the genome that codes for proteins. We provide high-depth, high-precision analysis for clinical diagnostics, rare Mendelian diseases, and complex oncology research.

Publication & Reporting Support

We do not just hand over raw VCFs. We provide publication-ready graphics (Lollipop plots for mutations, Waterfall plots for cancer cohorts) and comprehensive methodology write-ups suitable for medical journals.

For clinical researchers, we assist in formatting variant findings according to strict ACMG/AMP guidelines.

Whole Exome Analysis

Instrument & AI Pipeline

Instrument Compatibility

Standard Short-Read WES: Illumina (NovaSeq, NextSeq), MGI (DNBSEQ-G400, T7), AVITI (Element Biosciences), Thermo Fisher (Ion Proton/S5). Compatible with Agilent SureSelect, Twist Bioscience, and Illumina Nextera capture kits. Targeted Long-Read Panels: PacBio (Revio) and Oxford Nanopore for phasing clinically relevant exonic regions and resolving pseudogenes.

AI Pipeline & Data Quality

• Data Quality: Q30 > 80%, On-Target Rate > 70%. • Required Depth: >50x (Research), >100x (Clinical Mendelian), >200x to 500x (Somatic/Tumor). • AI Utilization: We integrate Google DeepVariant for highly accurate variant calling and Google AlphaMissense / PrimateAI-3D for state-of-the-art pathogenicity prediction of unknown missense variants. Tools: BWA-MEM, GATK4 (Mutect2 for somatic), DeepVariant, SnpEff, VEP, ExomeDepth, InterVar (ACMG).

Service Tiers & Deliverables

Research Exome Analysis

₹4,000 - ₹6,000 Standard Variant Calling & Annotation TAT: 2 - 4 Days Deliverables: BAM/BAI files, VCF, Annotated VCF (SnpEff/VEP), Target coverage metrics, and primary variant excel sheets.

Clinical / Tumor-Normal WES

₹5,000 - ₹7,500 Deep Coverage & ACMG Classification TAT: 4 - 6 Days Deliverables: Somatic VCFs, CNV calls, Tumor Mutational Burden (TMB) scoring, and phenotype-driven variant prioritization reports.

Analysis Capabilities

  • 1. Clinical Exome & Rare Diseases Identification of causative mutations in probands or family trios (Trio-WES). • Variant filtering based on population frequency (gnomAD, 1000G). • Pathogenicity classification following strict ACMG/AMP guidelines.
  • 2. Oncology & Somatic Calling Tumor-Normal paired analysis to identify driver mutations, tumor mutational burden (TMB), and microsatellite instability (MSI).
  • 3. Exonic CNV Detection Beyond SNPs and Indels, we utilize read-depth algorithms to detect Copy Number Variations (deletions/duplications) spanning individual or multiple exons.

Application Focus

•

Diagnostic Research: Solving diagnostic odysseys for inherited genetic disorders using phenotype-driven gene panels (HPO terms).

•

Cancer Genomics: Identifying actionable mutations for precision oncology and targeted therapeutics.

•

Population Studies: Discovering novel variants in specific ethnic cohorts and performing genome-wide association studies (GWAS) on exome data.

Frequently asked questions about whole exome sequencing

What is whole exome sequencing?
WES sequences the protein-coding regions of the genome, where most known disease-causing variants are found.
WES or WGS — which should I choose?
WES is more economical for coding variants; WGS also covers non-coding regions and structural variants.
What coverage do you provide?
Germline WES covers 19,433 genes at 100X coverage; somatic WES at 300X.
How much does it cost?
Germline WES is ₹20,000 and somatic WES is ₹28,500, with a 3-week turnaround. Request a quote at yaazhxenomics.com/quote, or call or WhatsApp +91 99431 32020.
AI-Driven Whole Exome Sequencing (WES) Analysis | YaazhXenomics